Barclays analyst Peter Lawson maintained a Buy rating on Syndax Pharmaceuticals (SNDX – Research Report) today and set a price target of $33.00. The company’s shares closed yesterday at $14.65 ...

Choosing the right iPhone often comes down to finding the perfect size for your needs. With Apple offering a range of models, from compact designs to the biggest iPhone on the market, knowing the ...

You might think there are only three adult mattress sizes – single, double and king – but adult mattresses actually come in 10 different sizes. Find out what they are and discover the most popular ...

The phase 3 waveLINE-010 trial is evaluating zilovertamab vedotin plus R-CHP vs R-CHOP for the treatment of untreated diffuse large B-cell lymphoma. The phase 3 waveLINE-010 trial (NCT06717347) ...

Here is a look back on all the FDA happenings from the month of January 2025. In January 2025, the FDA granted several key approvals in oncology, including acalabrutinib (Calquence) with bendamustine ...

Lois Borny works on the product review section of The Independent, IndyBest, where she helps readers to save money and shop savvy, scouting out the very best deals and sharing her tried and tested ...

After hours: February 7 at 7:26:40 PM EST Loading Chart for SNDX ...

After hours: February 7 at 7:56:10 PM EST Loading Chart for INCY ...